Wuhan Hvsen Ownership

Wuhan Hvsen Biotechnology retains a total of 165.77 Million outstanding shares. Wuhan Hvsen Biotechnology maintains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 60.51 (%) of Wuhan Hvsen Biotechnology outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Wuhan Hvsen in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Wuhan Hvsen, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. As of December 16, 2024, Dividends Paid is expected to decline to about 37.4 M. The current year's Net Income Applicable To Common Shares is expected to grow to about 96.4 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 162.2 M. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Wuhan Hvsen Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.